Skincare marketing operates on a different truth standard than clinical science. A clinical claim requires controlled studies, statistical significance, and reproducible results. A marketing claim requires only that it is not provably false in a literal reading. The gap between these two standards is where most skincare confusion originates.
Specific phrases are reliable indicators of marketing language. "Clinically proven" is meaningless without specifying what was measured, against what control, and with what statistical power. "Dermatologist-tested" means only that a dermatologist was involved at some point — not that the product passed any specific test. "Patented technology" can refer to the packaging, the delivery method, or entirely unrelated aspects of the product. None of these phrases convey information about efficacy.
Clinical language uses specific, bounded claims. "30% reduction in wrinkle depth after 12 weeks" is a clinical claim — it can be verified or falsified by measurement. "Reduces the appearance of fine lines" is a marketing claim — it is subjective, unmeasurable, and always true because reducing can mean anything from 99% improvement to an imperceptible change that only exists in the user's imagination.
The EU Cosmetics Regulation and FDA labeling requirements provide some protection, but the enforcement gap is significant. Most claims on skincare labels are not independently verified. A brand can claim "clinical results" based on an uncontrolled study of 12 people — barely enough for statistical significance but marketed as definitive proof. The user's best defence is looking for specific numbers, known standards, and reproducibility across independent sources.
NeoLabCare's policy is to use only claims that can be supported by published peer-reviewed research on the specific ingredients at the concentrations used. The brand makes no claim that is not traceable to a specific study, mechanism, or measurable outcome. If a claim cannot be phrased in clinical language, it should not be made at all.